
    
      Participants will receive a total of three vaccinations, one each at Day 0, Day 7, and Day
      28, respectively, and will be assessment for immune response to rabies vaccine before the
      first injection (baseline titer), at Day 42, and at Month 6.

      Safety will be assessed in all participants up to 28 days after each injection. Serious
      adverse events and adverse events of special interest (AESIs) will be collected up to 6
      months after the last injection.
    
  